[vc_row][vc_column width=”1/1″][mp_block_1 category_display=”root” post_sort=”date” post_limit=”3″ post_offset=”4″][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][mp_block_4 category_display=”root” post_sort=”date” post_limit=”4″ post_offset=”7″][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][vc_widget_sidebar sidebar_id=”content-ad-1″ el_class=”content-ad”][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][mp_block_6 category_display=”root” post_sort=”date” post_limit=”3″ post_offset=”11″][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][mp_block_6 category_display=”root” post_sort=”date” post_limit=”3″ post_offset=”14″][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][vc_widget_sidebar sidebar_id=”content-ad-2″][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][mp_block_6 category_display=”root” post_sort=”date” post_limit=”3″ post_offset=”18″][/vc_column][/vc_row]
Home
Recent Posts
- Partnership Aims to Lower Out-of-Pocket Costs for Rare Disease Meds
- Nominations Open for 2022 Eurordis Black Pearl Awards
- Potential Genome-editing Therapy Shows Promise in Fabry Mouse Model
- Experts Review Benefits, Challenges of Family Genetic Testing
- After 2-year Delay, 2nd Patient Dosed in FLT190 Gene Therapy Trial
- EveryLife Introduces First of Kind ‘Roadmap’ to ICD Codes
- How I Adapted to Gradual Hearing Loss Due to Fabry Disease
- Get Ready for NORD’s Patient and Family Forum, Set for June 26-27
- Film Animator’s New Mission: Calling Attention to ‘Fabry Fog’
- New Dosing Protocol May Shorten Fabrazyme Infusions